Characterization of patients with metastatic non-small-cell lung cancer obtaining long-term benefit from immunotherapy
Abstract
Aim: A minority of patients gains advantage from immunotherapy (IO). Predictive variables of long-term benefit (LTB) are incompletely understood. Materials & methods: We retrospectively collected data about metastatic non-small-cell lung cancer patients treated with IO from April 2013 to July 2017. We defined LTB to IO as complete response (CR), partial response (PR) or disease stability as best response and maintaining it for ≥12 months....
Paper Details
Title
Characterization of patients with metastatic non-small-cell lung cancer obtaining long-term benefit from immunotherapy
Published Date
Aug 1, 2019
Journal
Volume
15
Issue
23
Pages
2743 - 2757
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History